About INT

Integrated Nanotherapeutics (INT) is a biotech company in Vancouver, Canada focused on using nanotechnology to uncover and maximize the therapeutic potential of many drugs.

Our proprietary drug delivery platform technology can deliver any type of drug modality in lipid nanoparticles (LNPs), either alone or in combination, to disease tissues and cells. The outcome is safer and more effective medicines that improve human health. In addition, we are advancing a therapeutic platform that induces antigen-specific tolerance to treat autoimmune diseases.